99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells.

[1]  P. Romagnani,et al.  Peripheral blood as a source of stem cells for regenerative medicine , 2006, Expert opinion on biological therapy.

[2]  T. Stokke,et al.  The Response of Malignant B Lymphocytes to Ionizing Radiation: Cell Cycle Arrest, Apoptosis and Protection against the Cytotoxic Effects of the Mitotic Inhibitor Nocodazole , 2004, Radiation research.

[3]  S. Ritter,et al.  Cell cycle arrest and aberration yield in normal human fibroblasts. I. Effects of X‐rays and 195 MeV u−1 C ions , 2004, International journal of radiation biology.

[4]  M. Liberatore,et al.  The effects of 99mTc-HMPAO-labelled leucocyte scan on human karyotype , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[5]  E. Pauwels,et al.  Labeling of mixed leukocytes with (99m)Tc-HMPAO causes severe chromosomal aberrations in lymphocytes. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  I. Roninson,et al.  If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. , 2001, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[7]  G. Ferro-Flores,et al.  Assessment of radiation-induced DNA damage caused by the incorporation of 99mTc-radiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. , 2000, Mutation research.

[8]  C. de Labriolle-Vaylet,et al.  Biological consequences of the heterogeneous irradiation of lymphocytes during technetium-99m hexamethylpropylene amine oxime white blood cell labelling , 1998, European Journal of Nuclear Medicine.

[9]  M. Thakur,et al.  A consensus protocol for white blood cells labelling with technetium-99m hexamethylpropylene amine oxime , 1998, European Journal of Nuclear Medicine.

[10]  S. Jalkanen,et al.  Labelling lymphocytes with technetium99m-hexamethyl propyleneamine oxime for scintigraphy: an improved labelling procedure. , 1998, Journal of immunological methods.

[11]  P. Saba,et al.  Technetium-99m HMPAO labeled leukocytes as the primary diagnostic tool in a case of brain abscess. , 1997, Clinical Nuclear Medicine.

[12]  H. Thierens,et al.  Relationship of decreased chemotaxis of technetium-99m-HMPAO-labeled lymphocytes to apoptosis. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[13]  H. Thierens,et al.  Lymphocyte labeling with technetium-99m-HMPAO: a radiotoxicity study using the micronucleus assay. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  J. Cooper,et al.  Diagnosis of sternal wound infection by technetium-99m-leukocyte imaging. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  E. Lantto,et al.  Fast diagnosis of abdominal infections and inflammations with technetium-99m-HMPAO labeled leukocytes. , 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  E. Read,et al.  In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[17]  L. Mortelmans,et al.  In vitro and in vivo evaluation of granulocyte labeling with [99mTc]d,1-HM-PAO. , 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  S. Osman,et al.  Inflammation: imaging with Tc-99m HMPAO-labeled leukocytes. , 1988, Radiology.

[19]  S. Osman,et al.  CLINICAL EXPERIENCE WITH 99mTc-HEXAMETHYLPROPYLENE-AMINEOXIME FOR LABELLING LEUCOCYTES AND IMAGING INFLAMMATION , 1986, The Lancet.

[20]  J. Tatum,et al.  Technetium-99m-labeled lymphocytes: a radiotoxicity study. , 1986, Journal of Nuclear Medicine.

[21]  R. Heikkilä,et al.  A new method for rapid technetium-99m labelling of leucocytes: functional cell studies in vitro. , 1985, Scandinavian journal of clinical and laboratory investigation.

[22]  M. Thakur,et al.  The significance of chromosomal aberrations in indium-111-labeled lymphocytes. , 1984, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  E. V. van Royen,et al.  Labeling with indium-111 has detrimental effects on human lymphocytes: concise communication. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[24]  M. Meignan,et al.  Biological effects and irradiation dose induced in human lymphocytes in vitro by an intracellular radionuclide:99mTc. , 1983, Radiation research.

[25]  P. M. Chisholm,et al.  Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[26]  P. Frost,et al.  Recirculation of lymphocytes and the use of indium-111. , 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  A. Segal,et al.  Indium-111 labeling of leukocytes: a detrimental effect on neutrophil and lymphocyte function and an improved method of cell labelling , 1978 .